APOL1 and human African trypanosomiasis: APOA is known to have higher serum abundances in populations of African descent [16–18], while circulating APOL1 is known to confer resistance to African trypanosomiasis (sleeping sickness) [19, 20], primarily through presence of a G1 or G2 sequence variant, though presence of these variants also increases the risk of kidney disease [21].